Aurora Interactive and Galderma to develop the world leading digital dermatology research tool

Aurora Interactive is partnering with Galderma, a global leading pharmaceutical company specializing in the research, development and marketing of innovative medical solutions in dermatology. The partnership contract is aimed at developing its mScope communication platform and viewer for dermatology research & development at Galderma’s R&D center at Sophia Antipolis, France. Galderma forms licensing partnerships around innovative product candidates and technologies.

“The partnership between Aurora and Galderma will allow the adaptation of the best digital technology suite to achieve both companies ambitious goals,” said Pierre Le Fèvre, president and chief executive officer for Aurora Interactive. “We are extremely proud to be associated with furthering dermatology research. The decision to facilitate collaboration between researchers is consistent with our company’s collaborative Web 2.0 philosophy and mScope product” he added.

The 19.300-sq. meter state-of-the-art R&D center at Sophia Antipolis is Galderma’s largest facility and positions the company as the world’s leading investor in dermatology R&D. To drive sustained growth, Galderma invests approximately 20 percent of its revenues to discover and develop new drugs and access innovative technologies

About Galderma

Founded in 1981, Galderma is a joint venture between Nestlé and L’Oréal and today employs more than 3.000 people. The company, headed by President & CEO Humberto C. Antunes, has wholly-owned affiliates in 31 countries and a worldwide network of exclusive sales agents. In 2009, sales reached 978 million euros, an increase of 10.8%* over 2008. Committed to the future of dermatology, Galderma’s ambition is to be recognized as the most competent and successful innovation-based company focused exclusively on meeting the needs of dermatology patients and physicians.